Sorbisterit

Sorbisterit (Calcium Polystyrene Sulfonate) is a potassium binder used to reduce high potassium levels in the blood. It works by exchanging calcium for potassium in the digestive tract. This product is available for oral or rectal use.

Calcium Polystyrene Sulfonate is primarily used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. It is often prescribed when dietary restrictions are insufficient or when rapid potassium reduction is needed. The medication helps manage potassium levels in patients with kidney disease or those taking medications that increase potassium.

When taken as directed, Calcium Polystyrene Sulfonate binds to potassium in the digestive tract, helping to lower blood potassium levels. Users may notice improved energy levels and reduced symptoms associated with high potassium, such as muscle weakness or irregular heartbeat. Effects vary based on individual health conditions and adherence to treatment.

Calcium Polystyrene Sulfonate should be used under medical supervision to monitor potassium levels and potential side effects. It is important to follow the prescribed administration route and dosage. Patients should inform their healthcare provider about any existing conditions, such as bowel obstruction or severe constipation, before use. Regular blood tests may be required to ensure safe and effective treatment.

Calcium Polystyrene Sulfonate may interact with other medications that affect potassium levels, such as ACE inhibitors or potassium-sparing diuretics. It can also bind to other oral medications, potentially reducing their absorption. Alcohol and certain foods may influence its effectiveness. Always consult a healthcare provider before combining this medication with other treatments.